Xeris Biopharma Holdings
XERS
XERS
86 hedge funds and large institutions have $150M invested in Xeris Biopharma Holdings in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 21 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 24
30.74% less ownership
Funds ownership: 85.34% → 54.59% (-31%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
86
Holding in Top 10
–
Calls
$13.4M
Puts
$457K
Top Buyers
| 1 | +$4.32M | |
| 2 | +$3.53M | |
| 3 | +$2.48M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.99M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$1.9M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$8.46M | |
| 3 | -$2.89M | |
| 4 |
AGM
Alpine Global Management
New York
|
-$2.65M |
| 5 |
SFM
Soros Fund Management
New York
|
-$1.15M |